The Royal Marsden NHS Trust Sutton

Sutton SM2 5PT

1 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Castration-Resistant, Squamous Cell Carcinoma of Head and Neck

Studies at this site

• A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer — Recruiting now
• A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer — Running, not enrolling
• A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions — Running, not enrolling